Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

Research Site, Birmingham

Research Site, Cullman

Research Site, Gilbert

Research Site, Phoenix

Research Site, Aurora

Research Site, Centennial

Research Site, Washington D.C.

Research Site, Jacksonville Beach

Research Site, Palm Bay

Research Site, Tampa

Research Site, Athens

Research Site, Atlanta

Research Site, Idaho Falls

Research Site, Chicago

Research Site, Peoria

Research Site, Baton Rouge

Research Site, Glen Burnie

Research Site, Boston

Research Site, Farmington Hills

Research Site, Golden Valley

Research Site, Lincoln

Research Site, Teaneck

Research Site, Amherst

Research Site, East Meadow

Research Site, New York

Research Site, Charlotte

Research Site, Raleigh

Research Site, Columbus

Research Site, Gahanna

Research Site, Uniontown

Research Site, Oklahoma City

Research Site, Portland

Research Site, Altoona

Research Site, Pittsburgh

Research Site, Nashville

Research Site, Dallas

Research Site, Salt Lake City

Research Site, Newport News

Research Site, Norfolk

Research Site, Seattle

Research Site, Spokane

Research Site, Madison

Research Site, Milwaukee